| On the rise |
| (No of cos: 201)
Rs crore | Quarter ended | % Chng |
| Mar-03 | Mar-04 |
| Sales | 19025.16 | 25319.75 | 33.09 |
| Other income | 500.72 | 646.62 | 29.14 |
| OP | 3849.45 | 5091.93 | 32.28 |
| Interest | 440.90 | 301.60 | -31.59 |
| Gross profit | 3408.55 | 4790.33 | 40.54 |
| Depreciation | 960.67 | 930.33 | -3.16 |
| Tax | 484.73 | 793.98 | 63.80 |
| Net profit | 1963.15 | 3066.02 | 56.18 |
| OPM (%) | 20.23 | 20.11 | - |
| GPM (%) | 17.92 | 18.92 | - |
| NPM (%) | 10.32 | 12.11 | - |
| |
| Among major industry groups, the total net profit of the four cement companies that have declared results so far more than doubled, from Rs 87.28 crore in the quarter ended March 2003 to Rs 179.80 crore in the quarter ended March 2004, while sales increased 19 per cent from 792.25 crore to Rs 944.13 crore. |
| |
| The automobile ancillary sector also reported a smart growth in sales and bottomline during the quarter. The total net profit of the four automobile ancillary companies making engine parts increased by 118 per cent to Rs 125.66 crore (Rs 57.62 crore). Sales jumped by 35 per cent to Rs 701.86 crore (Rs 519.88 crore). |
| |
| The three companies in the automobiles two- and three-wheeler industry posted a 68 per cent growth in net profit and a 36 per cent rise in sales, while the 24 companies in the information technology industry posted a 25 per cent growth in sales and a 32 per cent jump in net profits. |
| |
| But the results of the 17 companies in the pharmaceuticals industry were disappointing after Ranbaxy Laboratories reported a 47 per cent decline in its bottomline during the quarter. The industry posted a 9 per cent growth in net profit and a 13.3 per cent in sales during the March 2004 quarter. |
| |
| Excluding Ranbaxy Laboratories, the net profits of the remaining 16 companies increased by 83 per cent despite a 35 per cent decline in sales. |
| |
|
| |
